The "Global Biologics Outsourcing Market" size was valued at US$ 14.56 billion in 2024 and is projected to reach US$ 28.92 billion by 2030, at a CAGR of 12.1% during the forecast period 2024-2030.
The "United States Biologics Outsourcing Market" size was valued at US$ 3.82 billion in 2024 and is projected to reach US$ 7.38 billion by 2030, at a CAGR of 11.6% during the forecast period 2024-2030.
Biologics outsourcing refers to the practice of pharmaceutical and biotechnology companies contracting third-party service providers for the production, research, and development of biologic products. Biologics are complex drugs made from living organisms, and outsourcing can cover a range of services, including drug development, manufacturing, clinical trials, and distribution. Companies typically turn to contract manufacturing organizations (CMOs), contract research organizations (CROs), or other specialized service providers to leverage their expertise, infrastructure, and cost-effective solutions. Outsourcing biologics helps companies accelerate time-to-market, reduce costs, and focus on core competencies while ensuring high-quality production that meets regulatory standards.
Contract development and manufacturing services for biological pharmaceuticals, including protein production, cell line development, and process optimization capabilities.
Report Overview
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
Biologics Outsourcing Market provides a deep insight into the global Biologics Outsourcing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics Outsourcing Market, Biologics Outsourcing Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, Biologics Outsourcing Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics Outsourcing market in any manner.
Global Biologics Outsourcing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Boehringer Ingelheim
- Catalent
- GenScript
- Innovent Biologics
- Syngene
- Shanghai Medicilon
- GL Biochem Corporation
- GVK Biosciences Private
- Horizon Discovery Group
- Selexis
- Lonza
- Abzena
- Adimab
By Type
- Antibody
- Recombinant
- Protein
- Vaccines
- Others
By Application
- Vaccine & Therapeutics Development
- Blood & Blood Related Products Testing
- Cellular and Gene Therapy
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologics Outsourcing Market
- Overview of the regional outlook of the Biologics Outsourcing Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biologics Outsourcing
1.2 Key Market Segments
1.2.1 Biologics Outsourcing Segment by Type
1.2.2 Biologics Outsourcing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biologics Outsourcing Market Overview
2.1 Global Market Overview
2.1.1 Global Biologics Outsourcing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics Outsourcing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biologics Outsourcing Market Competitive Landscape
3.1 Global Biologics Outsourcing Sales by Manufacturers (2019-2024)
3.2 Global Biologics Outsourcing Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics Outsourcing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics Outsourcing Sales Sites, Area Served, Product Type
3.6 Biologics Outsourcing Market Competitive Situation and Trends
3.6.1 Biologics Outsourcing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics Outsourcing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biologics Outsourcing Industry Chain Analysis
4.1 Biologics Outsourcing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biologics Outsourcing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biologics Outsourcing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics Outsourcing Sales Market Share by Type (2019-2024)
6.3 Global Biologics Outsourcing Market Size Market Share by Type (2019-2024)
6.4 Global Biologics Outsourcing Price by Type (2019-2024)
7 Biologics Outsourcing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics Outsourcing Market Sales by Application (2019-2024)
7.3 Global Biologics Outsourcing Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics Outsourcing Sales Growth Rate by Application (2019-2024)
8 Biologics Outsourcing Market Segmentation by Region
8.1 Global Biologics Outsourcing Sales by Region
8.1.1 Global Biologics Outsourcing Sales by Region
8.1.2 Global Biologics Outsourcing Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics Outsourcing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics Outsourcing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics Outsourcing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics Outsourcing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics Outsourcing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Biologics Outsourcing Basic Information
9.1.2 Boehringer Ingelheim Biologics Outsourcing Product Overview
9.1.3 Boehringer Ingelheim Biologics Outsourcing Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Biologics Outsourcing SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 Catalent
9.2.1 Catalent Biologics Outsourcing Basic Information
9.2.2 Catalent Biologics Outsourcing Product Overview
9.2.3 Catalent Biologics Outsourcing Product Market Performance
9.2.4 Catalent Business Overview
9.2.5 Catalent Biologics Outsourcing SWOT Analysis
9.2.6 Catalent Recent Developments
9.3 GenScript
9.3.1 GenScript Biologics Outsourcing Basic Information
9.3.2 GenScript Biologics Outsourcing Product Overview
9.3.3 GenScript Biologics Outsourcing Product Market Performance
9.3.4 GenScript Biologics Outsourcing SWOT Analysis
9.3.5 GenScript Business Overview
9.3.6 GenScript Recent Developments
9.4 Innovent Biologics
9.4.1 Innovent Biologics Biologics Outsourcing Basic Information
9.4.2 Innovent Biologics Biologics Outsourcing Product Overview
9.4.3 Innovent Biologics Biologics Outsourcing Product Market Performance
9.4.4 Innovent Biologics Business Overview
9.4.5 Innovent Biologics Recent Developments
9.5 Syngene
9.5.1 Syngene Biologics Outsourcing Basic Information
9.5.2 Syngene Biologics Outsourcing Product Overview
9.5.3 Syngene Biologics Outsourcing Product Market Performance
9.5.4 Syngene Business Overview
9.5.5 Syngene Recent Developments
9.6 Shanghai Medicilon
9.6.1 Shanghai Medicilon Biologics Outsourcing Basic Information
9.6.2 Shanghai Medicilon Biologics Outsourcing Product Overview
9.6.3 Shanghai Medicilon Biologics Outsourcing Product Market Performance
9.6.4 Shanghai Medicilon Business Overview
9.6.5 Shanghai Medicilon Recent Developments
9.7 GL Biochem Corporation
9.7.1 GL Biochem Corporation Biologics Outsourcing Basic Information
9.7.2 GL Biochem Corporation Biologics Outsourcing Product Overview
9.7.3 GL Biochem Corporation Biologics Outsourcing Product Market Performance
9.7.4 GL Biochem Corporation Business Overview
9.7.5 GL Biochem Corporation Recent Developments
9.8 GVK Biosciences Private
9.8.1 GVK Biosciences Private Biologics Outsourcing Basic Information
9.8.2 GVK Biosciences Private Biologics Outsourcing Product Overview
9.8.3 GVK Biosciences Private Biologics Outsourcing Product Market Performance
9.8.4 GVK Biosciences Private Business Overview
9.8.5 GVK Biosciences Private Recent Developments
9.9 Horizon Discovery Group
9.9.1 Horizon Discovery Group Biologics Outsourcing Basic Information
9.9.2 Horizon Discovery Group Biologics Outsourcing Product Overview
9.9.3 Horizon Discovery Group Biologics Outsourcing Product Market Performance
9.9.4 Horizon Discovery Group Business Overview
9.9.5 Horizon Discovery Group Recent Developments
9.10 Selexis
9.10.1 Selexis Biologics Outsourcing Basic Information
9.10.2 Selexis Biologics Outsourcing Product Overview
9.10.3 Selexis Biologics Outsourcing Product Market Performance
9.10.4 Selexis Business Overview
9.10.5 Selexis Recent Developments
9.11 Lonza
9.11.1 Lonza Biologics Outsourcing Basic Information
9.11.2 Lonza Biologics Outsourcing Product Overview
9.11.3 Lonza Biologics Outsourcing Product Market Performance
9.11.4 Lonza Business Overview
9.11.5 Lonza Recent Developments
9.12 Abzena
9.12.1 Abzena Biologics Outsourcing Basic Information
9.12.2 Abzena Biologics Outsourcing Product Overview
9.12.3 Abzena Biologics Outsourcing Product Market Performance
9.12.4 Abzena Business Overview
9.12.5 Abzena Recent Developments
9.13 Adimab
9.13.1 Adimab Biologics Outsourcing Basic Information
9.13.2 Adimab Biologics Outsourcing Product Overview
9.13.3 Adimab Biologics Outsourcing Product Market Performance
9.13.4 Adimab Business Overview
9.13.5 Adimab Recent Developments
10 Biologics Outsourcing Market Forecast by Region
10.1 Global Biologics Outsourcing Market Size Forecast
10.2 Global Biologics Outsourcing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics Outsourcing Market Size Forecast by Country
10.2.3 Asia Pacific Biologics Outsourcing Market Size Forecast by Region
10.2.4 South America Biologics Outsourcing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics Outsourcing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biologics Outsourcing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics Outsourcing by Type (2025-2030)
11.1.2 Global Biologics Outsourcing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics Outsourcing by Type (2025-2030)
11.2 Global Biologics Outsourcing Market Forecast by Application (2025-2030)
11.2.1 Global Biologics Outsourcing Sales (K Units) Forecast by Application
11.2.2 Global Biologics Outsourcing Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics Outsourcing Market Size Comparison by Region (M USD)
Table 5. Global Biologics Outsourcing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biologics Outsourcing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics Outsourcing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics Outsourcing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Outsourcing as of 2022)
Table 10. Global Market Biologics Outsourcing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics Outsourcing Sales Sites and Area Served
Table 12. Manufacturers Biologics Outsourcing Product Type
Table 13. Global Biologics Outsourcing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics Outsourcing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics Outsourcing Market Challenges
Table 22. Global Biologics Outsourcing Sales by Type (K Units)
Table 23. Global Biologics Outsourcing Market Size by Type (M USD)
Table 24. Global Biologics Outsourcing Sales (K Units) by Type (2019-2024)
Table 25. Global Biologics Outsourcing Sales Market Share by Type (2019-2024)
Table 26. Global Biologics Outsourcing Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics Outsourcing Market Size Share by Type (2019-2024)
Table 28. Global Biologics Outsourcing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biologics Outsourcing Sales (K Units) by Application
Table 30. Global Biologics Outsourcing Market Size by Application
Table 31. Global Biologics Outsourcing Sales by Application (2019-2024) & (K Units)
Table 32. Global Biologics Outsourcing Sales Market Share by Application (2019-2024)
Table 33. Global Biologics Outsourcing Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics Outsourcing Market Share by Application (2019-2024)
Table 35. Global Biologics Outsourcing Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics Outsourcing Sales by Region (2019-2024) & (K Units)
Table 37. Global Biologics Outsourcing Sales Market Share by Region (2019-2024)
Table 38. North America Biologics Outsourcing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biologics Outsourcing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biologics Outsourcing Sales by Region (2019-2024) & (K Units)
Table 41. South America Biologics Outsourcing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biologics Outsourcing Sales by Region (2019-2024) & (K Units)
Table 43. Boehringer Ingelheim Biologics Outsourcing Basic Information
Table 44. Boehringer Ingelheim Biologics Outsourcing Product Overview
Table 45. Boehringer Ingelheim Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Biologics Outsourcing SWOT Analysis
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Catalent Biologics Outsourcing Basic Information
Table 50. Catalent Biologics Outsourcing Product Overview
Table 51. Catalent Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Catalent Business Overview
Table 53. Catalent Biologics Outsourcing SWOT Analysis
Table 54. Catalent Recent Developments
Table 55. GenScript Biologics Outsourcing Basic Information
Table 56. GenScript Biologics Outsourcing Product Overview
Table 57. GenScript Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GenScript Biologics Outsourcing SWOT Analysis
Table 59. GenScript Business Overview
Table 60. GenScript Recent Developments
Table 61. Innovent Biologics Biologics Outsourcing Basic Information
Table 62. Innovent Biologics Biologics Outsourcing Product Overview
Table 63. Innovent Biologics Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Innovent Biologics Business Overview
Table 65. Innovent Biologics Recent Developments
Table 66. Syngene Biologics Outsourcing Basic Information
Table 67. Syngene Biologics Outsourcing Product Overview
Table 68. Syngene Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Syngene Business Overview
Table 70. Syngene Recent Developments
Table 71. Shanghai Medicilon Biologics Outsourcing Basic Information
Table 72. Shanghai Medicilon Biologics Outsourcing Product Overview
Table 73. Shanghai Medicilon Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Shanghai Medicilon Business Overview
Table 75. Shanghai Medicilon Recent Developments
Table 76. GL Biochem Corporation Biologics Outsourcing Basic Information
Table 77. GL Biochem Corporation Biologics Outsourcing Product Overview
Table 78. GL Biochem Corporation Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. GL Biochem Corporation Business Overview
Table 80. GL Biochem Corporation Recent Developments
Table 81. GVK Biosciences Private Biologics Outsourcing Basic Information
Table 82. GVK Biosciences Private Biologics Outsourcing Product Overview
Table 83. GVK Biosciences Private Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GVK Biosciences Private Business Overview
Table 85. GVK Biosciences Private Recent Developments
Table 86. Horizon Discovery Group Biologics Outsourcing Basic Information
Table 87. Horizon Discovery Group Biologics Outsourcing Product Overview
Table 88. Horizon Discovery Group Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Horizon Discovery Group Business Overview
Table 90. Horizon Discovery Group Recent Developments
Table 91. Selexis Biologics Outsourcing Basic Information
Table 92. Selexis Biologics Outsourcing Product Overview
Table 93. Selexis Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Selexis Business Overview
Table 95. Selexis Recent Developments
Table 96. Lonza Biologics Outsourcing Basic Information
Table 97. Lonza Biologics Outsourcing Product Overview
Table 98. Lonza Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Lonza Business Overview
Table 100. Lonza Recent Developments
Table 101. Abzena Biologics Outsourcing Basic Information
Table 102. Abzena Biologics Outsourcing Product Overview
Table 103. Abzena Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Abzena Business Overview
Table 105. Abzena Recent Developments
Table 106. Adimab Biologics Outsourcing Basic Information
Table 107. Adimab Biologics Outsourcing Product Overview
Table 108. Adimab Biologics Outsourcing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Adimab Business Overview
Table 110. Adimab Recent Developments
Table 111. Global Biologics Outsourcing Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Biologics Outsourcing Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Biologics Outsourcing Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Biologics Outsourcing Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Biologics Outsourcing Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Biologics Outsourcing Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Biologics Outsourcing Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Biologics Outsourcing Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Biologics Outsourcing Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Biologics Outsourcing Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Biologics Outsourcing Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Biologics Outsourcing Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Biologics Outsourcing Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Biologics Outsourcing Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Biologics Outsourcing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Biologics Outsourcing Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Biologics Outsourcing Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Biologics Outsourcing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics Outsourcing Market Size (M USD), 2019-2030
Figure 5. Global Biologics Outsourcing Market Size (M USD) (2019-2030)
Figure 6. Global Biologics Outsourcing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics Outsourcing Market Size by Country (M USD)
Figure 11. Biologics Outsourcing Sales Share by Manufacturers in 2023
Figure 12. Global Biologics Outsourcing Revenue Share by Manufacturers in 2023
Figure 13. Biologics Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics Outsourcing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics Outsourcing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics Outsourcing Market Share by Type
Figure 18. Sales Market Share of Biologics Outsourcing by Type (2019-2024)
Figure 19. Sales Market Share of Biologics Outsourcing by Type in 2023
Figure 20. Market Size Share of Biologics Outsourcing by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics Outsourcing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics Outsourcing Market Share by Application
Figure 24. Global Biologics Outsourcing Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics Outsourcing Sales Market Share by Application in 2023
Figure 26. Global Biologics Outsourcing Market Share by Application (2019-2024)
Figure 27. Global Biologics Outsourcing Market Share by Application in 2023
Figure 28. Global Biologics Outsourcing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics Outsourcing Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biologics Outsourcing Sales Market Share by Country in 2023
Figure 32. U.S. Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biologics Outsourcing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics Outsourcing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biologics Outsourcing Sales Market Share by Country in 2023
Figure 37. Germany Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biologics Outsourcing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biologics Outsourcing Sales Market Share by Region in 2023
Figure 44. China Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biologics Outsourcing Sales and Growth Rate (K Units)
Figure 50. South America Biologics Outsourcing Sales Market Share by Country in 2023
Figure 51. Brazil Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biologics Outsourcing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biologics Outsourcing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biologics Outsourcing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biologics Outsourcing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biologics Outsourcing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics Outsourcing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics Outsourcing Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics Outsourcing Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics Outsourcing Market Share Forecast by Application (2025-2030)
